Strategic collaboration Neura Health has formed high-profile funding and partnership activity, including Series A with Heart-Go Red Venture Fund and a strategic collaboration with Eli Lilly. This indicates openness to co-development and large-scale healthcare partnerships that can be leveraged for joint program opportunities, especially around migraine care and neurology-focused solutions.

Scaleable access The company operates a national tele-neurology network delivering video visits typically within a week, suggesting strong capability to expand payer- and employer-focused neurology access programs, rapid deployment of virtual care, and scalable patient enrollment for large health plans.

Cost and outcome leverage Neurology is a top five expense area for health plans; Neura positions itself as a path to cost savings and improved outcomes. This presents sales angles with insurers and employer groups seeking to optimize neurology-related spend and reduce long-term costs through proactive care.

Diverse care offerings In addition to neurology, Neura has expanded into virtual sleep care for employers and handles undiagnosed symptoms, migraines, epilepsy, and post-COVID conditions. This breadth creates cross-sell opportunities with employers and health systems seeking comprehensive, multi-condition virtual care programs.

Clinical credibility Peer‑reviewed outcomes published in 2022 and 2023 and a leadership team with board-certified neurologists underpin trust with enterprise buyers. Use this to support proposals to health plans, large employers, and hospital systems emphasizing validated quality of care.